Back to 
RA Capital Management, L.P.
RA Capital Management, L.P.
IOVA
Showing 0 of 3 quarters
Position history for RA Capital Management, L.P.'s holdings in Iovance Biotherapeutics, Inc.
No. RA Capital Management exited its IOVA (Iovance Biotherapeutics) position in Q2 2019. Its Q1 2019 13F listed 2,610,510 shares worth $24.8M. RA Capital Management already held IOVA in its Q4 2018 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.